French rule in favour of blood victims:
This article was originally published in Clinica
The French Appeals Court has ruled that people who contracted HIV or hepatitis C from contaminated blood at a public institution should be compensated in the same way as those infected at a private clinic - no-fault liability. Compensation for those infected with HIV from transfusions is set at about Fr 2 million ($330,000) and at Fr 200,000-800,000 for those infected with hepatitis C, says Les Echos.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.